| |
|
|
| Name: |
Novo A/S |
| City: |
HELLERUP |
| State: |
G7 |
| Zip: |
2900 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
21 |
|
View All Holdings |
Currently
Viewing:
Unchanged Positions |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
BN |
BROOKFIELD Corp |
2 |
- |
$41.52 |
$162,465,000 |
3,880,230 |
11.21% |
6,790,000 |
0 |
0.249 |
N/A |
|
|
CORT |
Corcept Therapeutics Inc |
5 |
- |
$33.31 |
$60,742,000 |
2,411,362 |
4.19% |
-17,579,000 |
0 |
2.068 |
Biotechnology |
|
|
PCVX |
Vaxcyte, Inc. |
6 |
- |
$0.00 |
$57,722,000 |
845,000 |
3.98% |
4,656,000 |
0 |
0.783 |
N/A |
|
|
CABO |
Cable One, Inc. |
8 |
- |
$374.72 |
$50,100,000 |
118,403 |
3.46% |
-15,802,000 |
0 |
1.967 |
N/A |
|
|
LNZA |
LanzaTech Global, Inc |
9 |
- |
$2.07 |
$48,947,000 |
15,814,845 |
3.38% |
-30,602,000 |
0 |
8.091 |
N/A |
|
|
BMRN |
Biomarin Pharmaceutical Inc |
11 |
- |
$88.63 |
$39,303,000 |
450,000 |
2.71% |
-4,086,000 |
0 |
0.239 |
Drug Manufacturers - ... |
|
|
MIRM |
Mirum Pharmaceuticals, Inc. |
12 |
- |
$0.00 |
$37,680,000 |
1,500,000 |
2.6% |
-6,600,000 |
0 |
2.798 |
N/A |
|
|
INSM |
Insmed Inc |
13 |
- |
$56.85 |
$36,335,000 |
1,339,304 |
2.51% |
-5,170,000 |
0 |
0.884 |
Biotechnology |
|
|
BABA |
Alibaba Group Holding Limited |
14 |
- |
$78.41 |
$36,240,000 |
500,827 |
2.5% |
-2,579,000 |
0 |
0.018 |
N/A |
|
|
FOLD |
Amicus Therapeutics Inc |
17 |
- |
$10.61 |
$29,450,000 |
2,500,000 |
2.03% |
-6,025,000 |
0 |
0.735 |
Biotechnology |
|
|
RCKT |
Rocket Pharmaceuticals |
18 |
- |
$22.68 |
$28,287,000 |
1,050,000 |
1.95% |
-3,182,000 |
0 |
1.134 |
N/A |
|
|
CRGX |
Cargo Therapeutics, Inc. |
19 |
- |
$0.00 |
$27,900,000 |
1,250,000 |
1.92% |
-1,038,000 |
0 |
0 |
N/A |
|
|
VERV |
Verve Therapeutics, Inc. |
21 |
- |
$0.00 |
$26,560,000 |
2,000,000 |
1.83% |
-1,320,000 |
0 |
2.487 |
N/A |
|
|
BAM |
Brookfield Asset Management... |
22 |
- |
$37.95 |
$26,355,000 |
627,207 |
1.82% |
1,160,000 |
0 |
0.152 |
Asset Management |
|
|
ALNY |
Alnylam Pharmaceuticals Inc |
27 |
- |
$152.78 |
$17,692,000 |
118,383 |
1.22% |
-4,968,000 |
0 |
0.096 |
Biotechnology |
|
|
INSP |
Inspire Medical Systems Inc |
29 |
- |
$157.79 |
$14,074,000 |
65,524 |
0.97% |
744,000 |
0 |
0.201 |
N/A |
|
|
ABCL |
Abcellera Biologics Inc. |
31 |
- |
$0.00 |
$5,105,000 |
1,126,915 |
0.35% |
-1,330,000 |
0 |
0.419 |
N/A |
|
|
TMCI |
Treace Medical Concepts, Inc. |
32 |
- |
$5.91 |
$4,698,000 |
360,000 |
0.32% |
108,000 |
0 |
0.682 |
N/A |
|
|
MQ |
Marqeta, Inc. |
33 |
- |
$5.25 |
$2,632,000 |
441,558 |
0.18% |
-450,000 |
0 |
0.099 |
N/A |
|
|
GLTO |
Galecto Inc. |
34 |
- |
$0.00 |
$1,948,000 |
2,497,791 |
0.13% |
150,000 |
0 |
9.888 |
N/A |
|
|
SPRO |
Spero Therapeutics Inc |
35 |
- |
$1.41 |
$807,000 |
468,902 |
0.06% |
-122,580,000 |
0 |
1.724 |
N/A |
|
